Las Vegas, NV -- (SBWIRE) -- 01/13/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Aeropostale Inc (NYSE:ARO), AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Cole Real Estate Investments Inc (NYSE:COLE), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
Aeropostale Inc (NYSE:ARO) ended its recent business day with the tumbled of -6.02% and closed at the price of $8.43 after opening at $9.06. The stock traded during its last trading session with the total volume of 7.59 million shares, as compared to its average volume of 3.44 million shares. Aéropostale, Inc., together with its subsidiaries, operates as a mall-based specialty retailer of casual apparel and accessories.
Has ARO Found The Bottom And Ready To Gain Momentum? Find Out Here
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) remained among the day bullish 5.04% and traded with volume of 5.61 million shares in the last session, as compared to average volume of 2.58 million shares. In comparison with 52 week range of $0.99 - $3.45, it faced lowest price of $1.19 during the last trading session whereas its day highest price was $1.30. The company’s total market capitalization is $56.41 million, along with 45.13 million shares outstanding. Aeterna Zentaris Inc., a specialty biopharmaceutical company, is engaged in developing and commercializing treatments in oncology and endocrinology worldwide.
Will AEZS Continue To Move Higher? Find out via this report
Cole Real Estate Investments Inc (NYSE:COLE) showed 10.39 million shares in volume during the last trading session, while the average trading volume remained 3.77 million shares. The stock kicked off its trading session at $13.76 and closed at $14.19 after rallied 2.23%. Cole Real Estate Investments, Inc. is a publicly owned real estate investment trust. The trust invests in real estate markets of United States.
Why Should Investors Buy COLE After The Recent Gain? Just Go Here and Find Out
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock traded during its last trading session with the total traded volume of 5.69 million shares versus its average volume of 4.14 million shares. The company opened its trade at the price of $6.15 and its closing price was $6.37 after gained 5.12% for the day. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
For How Long ARNA will Fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)